1. Home
  2. UTHR vs WSM Comparison

UTHR vs WSM Comparison

Compare UTHR & WSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United Therapeutics Corporation

UTHR

United Therapeutics Corporation

HOLD

Current Price

$487.75

Market Cap

23.1B

Sector

Health Care

ML Signal

HOLD

Logo Williams-Sonoma Inc. (DE)

WSM

Williams-Sonoma Inc. (DE)

HOLD

Current Price

$221.89

Market Cap

26.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTHR
WSM
Founded
1996
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Home Furnishings
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
23.1B
26.2B
IPO Year
1999
1995

Fundamental Metrics

Financial Performance
Metric
UTHR
WSM
Price
$487.75
$221.89
Analyst Decision
Buy
Buy
Analyst Count
14
14
Target Price
$567.57
$209.71
AVG Volume (30 Days)
467.9K
816.0K
Earning Date
05-06-2026
05-21-2026
Dividend Yield
N/A
1.68%
EPS Growth
13.07
0.57
EPS
13.07
4.77
Revenue
$1,483,300,000.00
$7,806,816,000.00
Revenue This Year
$6.39
$5.37
Revenue Next Year
$14.18
$4.50
P/E Ratio
$37.66
$46.48
Revenue Growth
2.38
1.24
52 Week Low
$375.61
$165.51
52 Week High
$609.35
$254.89

Technical Indicators

Market Signals
Indicator
UTHR
WSM
Relative Strength Index (RSI) 35.32 33.88
Support Level $464.92 $214.98
Resistance Level $489.48 $249.20
Average True Range (ATR) 13.13 7.92
MACD -1.88 -2.85
Stochastic Oscillator 21.13 7.14

Price Performance

Historical Comparison
UTHR
WSM

About UTHR United Therapeutics Corporation

United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. It derives maximum revenue from the sale of Tyvaso DPI. Geographically, the company operates in United States and Rest of the World, of which United States generates majority of the revenue.

About WSM Williams-Sonoma Inc. (DE)

With a retail and direct-to-consumer presence, Williams-Sonoma is a player in the nearly $300 billion domestic home category and $450 billion international home market, focused on expanding its exposure in the B2B ($80 billion total addressable market), marketplace, and franchise areas. Namesake Williams-Sonoma (153 stores) offers high-end cooking essentials, while Pottery Barn (181) provides casual home accessories. West Elm (117) is an emerging concept for young professionals, and Rejuvenation (13) offers lighting and house parts. Brand extensions include Pottery Barn Kids and Pottery Barn Teen (43) as well as Mark & Graham and GreenRow. Williams-Sonoma also has a business-to-business team that supports projects that range from residential to large-scale commercial.

Share on Social Networks: